dsRBD Redesign: A Targeted Strategy for Inhibition of RNA Helicase DHX9
This paper presents a computationally designed protein binder strategy that targets the autoregulatory interface between the DHX9 helicase core and its dsRBD2 domain to specifically inhibit DHX9 activity for cancer therapy, offering an efficient alternative to traditional library-based screening methods.